MCC Update 01-28-14
Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, email@example.com, by Noon on the Fridays for publication the following Tuesday.
January 28, 2014
Today's seminar will be simulcast to 450 MCRB. Shuttles to CCRB are also available and may be boarded in front of Variety Club Heart Clinic on E. River Parkway. See website for details on pick-up time.
Tuesday, January 28, 2014, 12-1 p.m., 1-125 CCRB
Innate and adaptive immunity within the tumor microenvironment
Thomas Gajewski, M.D., Ph.D., Professor, Department of Medicine, The University of Chicago
Host: Yoji Shimizu, Ph.D.
A peek at the next seminar:
Tuesday, February 4, 2014, 12-1 p.m., 1-125 CCRB
Medicinal chemistry effort in cancer treatment, prevention, and early detection
Chengguo Xing, Ph.D., Associate Professor, Department of Medicinal Chemistry, University of Minnesota
Visit the calendar for a schedule of seminars.
Members in the news
The research of Edward Greeno, M.D., Tumor Microenvironment Program, is featured in a National Public Radio story “Western Scientists Look To Chinese Medicine For Fresh Leads.”
Members receives grants
Jatinder Lamba, Ph.D., Genetic Mechanisms of Cancer Program, was the recipient of an Academic Health Center Grant-in-Aid award for her study “Pharmacogenomics of Ara-C in AML.
Melissa Geller, M.D., Transplant Biology and Therapy Program, Hee Yun Lee, Ph.D., Prevention and Etiology Program, and Kristin Niendorf, M.S., CGC, were awarded an Ovarian Cancer Pilot Award of $225,000 over two years from the U.S. Department of Defense Health Program. The Mobile Health Genetic Counseling (mAGIC) study aims to develop and assess an intervention using mobile phone technology to promote genetic counseling among women with ovarian cancer and their families.
The following clinical trials conducted by Masonic Cancer Center members were recently opened:
MT 2013-03R Impact of radiation therapy, gender and frailty on the geriatric hematopoietic cell transplant and advanced heme-malignancy population
PI: Arora, Mukta
HM2012-19 :A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Group Study of A Lenalidomide (Revlimid®) Regimen or A Sequential Azacitidine (Vidaza®) plus Lenalidomide (Revlimid®) Regimen versus An Azacitidine (Vidaza®) Regimen for Therapy of Older Subjects with Newly Diagnosed Acute Myeloid Leukemia (CC-5013-AML-001)
PI: Warlick, Erica
MT2013-04 :A Phase II Study of Treosulfan/Fludarabine/Low Dose Total Body Irradiation as a Preparative Regimen for Children with AML/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
PI: Verneris, Michael
For more information on clinical trials contact Marva Bohen, R.N., B.S.N. (firstname.lastname@example.org, 612-624-2620).
January 29, 2014: Lab Medicine and Pathology Grand Rounds
8-9 a.m., 450 MCRB
Breast cancer intra- and inter-tumor genetic heterogeneity
Jorge S. Reis-Filho, M.D., Ph.D., F.R.C.Path
February 18, 2014: Success in Lean Times (We're Talking About NIH)
12-1 p.m., 717 Delaware Street Southeast, Room 105
At this lunch seminar, you'll learn strategies for securing funding in a tough economic climate. Jasjit S. Ahluwalia, MD, MPH, MS, will lead an interactive discussion and Q&A to offer insight into the NIH funding process and share tips for being successful in lean times. This session is part of a new seminar series from the Clinical and Translational Science Institute (CTSI) that assists junior faculty in developing strong applications for NIH funding, other sources of national extramural funding, and CTSI career development programs. RSVP by Feb. 14 to email@example.com to reserve your lunch.
Visit the Education and Training Opportunities web page for more conference and special lecture listings.
January 6-February 28, 2014: Breast Cancer Superhero Portrait Project
Roen Room (W120), Boynton Health Service, 410 Church St. S.E., University of Minnesota
The Breast Cancer Superhero Portrait Project, created by Division of Hematology, Oncology and Transplantation staff member Barbara Porwit, will be exhibited at Boynton Health Service. The goal of the project is to celebrate and inspire the heroic nature of individuals affected by breast cancer. A brand-new portrait, "Her Honorable and Joyful Lady Justice" of a local woman Suzi Kazal Forst who was diagnosed with inflammatory breast cancer at the age of 36, will be unveiled at the opening reception on Friday, January 31, 5-7 p.m. Refreshments will be served. RSVP to firstname.lastname@example.org.
The Roen Room is generally open during Boynton's open hours but can be booked for meetings and classes, so best for people to check with Bickie Nguyen 624-4690 before heading over to view.
For more information on the project:
May 17, 2014: Save the Date: Cancer Survivorship Series
Click here to be added to the Cancer Survivor Program mailing list to receive registration information for this conference when it is available closer to the date.
Visit the Community Events and Outreach page for more information.
News & Notices:
Notice of Intent to Publish a Funding Opportunity Announcement for Physical Sciences-Oncology Centers Program (U54)
National Cancer Institute
NIH Operates Under a Continuing Resolution
Office of the Director, NIH
NIH Salary Cap increases to $181,500 Effective January 14, 2014
By Executive Order 13655
Mentored Career Development Award in Biomedical Big Data Science for Clinicians and Doctorally Prepared Scientists (K01)
National Cancer Institute
Application Receipt Date(s): April 1, 2014; April 1, 2015
Funding: NIH will contribute up to $167,000 per year toward the salary of the career award recipient, and $40,000 in research expenses per year.
Cancer Research Network Pilot Projects & Developmental Projects
Cancer Research Network, National Cancer Institute
Required Letter of Intent Deadline: March 3, 2014
Full Application Deadline: May 16, 2014
Funding: $75,000 for 1 year
Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.